<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 21-year-old man with homozygous <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> maintained on <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> for 1 year developed <z:mp ids='MP_0005048'>thrombosis</z:mp> of the superior sagittal, right transverse, and right sigmoid dural sinuses with a large venous <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>He was successfully treated with endovascular thrombolysis </plain></SENT>
<SENT sid="2" pm="."><plain>Investigation did not reveal any inherited or acquired <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>This patient however had consistently elevated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels both at the time of the initial event and on follow up </plain></SENT>
<SENT sid="4" pm="."><plain>One year later he developed symptomatic <z:hpo ids='HP_0010885'>avascular necrosis</z:hpo> of the right hip </plain></SENT>
<SENT sid="5" pm="."><plain>High <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels resulting from <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> therapy may have contributed to development of complications in this patient </plain></SENT>
</text></document>